Ikarian Capital, LLC Spring Works Therapeutics, Inc. Call Options Transaction History
Ikarian Capital, LLC
- $573 Million
- Q3 2024
Call Options
1 transactions
Others Institutions Holding SWTX
# of Institutions
238Shares Held
69.8MCall Options Held
144KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA6.71MShares$262 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$219 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.84MShares$150 Million4.54% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.52MShares$137 Million0.01% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$134 Million5.82% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.43B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...